SEC Form 4 · accession 0001493152-15-000867
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Carusone
Officer — VP, Investor Relations# · Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 18, 2015 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 10, 2015 | S | 2,100,000 | $0.0001 | D | 2,100,000 | D | |
| Common StockF1 | Mar 10, 2015 | S | 2,100,000 | $0.0001 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amount gives effect to a 3-for-1 stock split that was effective as of August 7, 2013.
Remarks
# - Mr. Carusone ceased to be an executive officer and a director as of March 10, 2015.